Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Devic's Neuromyelitis Optica”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Not applicableLooking for participantsNCT06941584
What this trial is testing

Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies

Who this might be right for
AIRE Deficiency
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Not applicableLooking for participantsNCT06541626
What this trial is testing

Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases

Who this might be right for
Multiple Sclerosis, MSNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+3 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 450
Testing effectiveness (Phase 2)Study completedNCT05551598
What this trial is testing

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 46
Testing effectiveness (Phase 2)Study completedNCT02249676
What this trial is testing

Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Devic's SyndromeDevic's Neuromyelitis OpticaDevic Syndrome+2 more
Tianjin Medical University General Hospital 15
Not applicableUnknownNCT05070286
What this trial is testing

Lifestyle Weight Management Program: Interviews and Stakeholder Meetings.

Who this might be right for
Multiple SclerosisNeuromyelitis Optica
Oxford Brookes University 45
Large-scale testing (Phase 3)Looking for participantsNCT07557420
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMOSDNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 19
Not applicableUnknownNCT04601142
What this trial is testing

Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica (NMO) and Gene Polymorphism

Who this might be right for
Glucocorticoid ResistanceGeneNeuromyelitis Optica
Beijing Tongren Hospital 350
Early research (Phase 1)Active Not RecruitingNCT05792462
What this trial is testing

Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum Disorder
Tianjin Medical University General Hospital 11
Not applicableLooking for participantsNCT07377305
What this trial is testing

Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMO Spectrum Disorder
Tang-Du Hospital 12
Not applicableStudy completedNCT03121105
What this trial is testing

Pathologic-MRI Findings in Atypical IIDD

Who this might be right for
Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
University Hospital, Montpellier 25
Not applicableUnknownNCT05284175
What this trial is testing

Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Peking Union Medical College Hospital 23
Large-scale testing (Phase 3)Looking for participantsNCT05199688
What this trial is testing

Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum DisorderNMOSD
Hoffmann-La Roche 8
Not applicableNot Yet RecruitingNCT07266051
What this trial is testing

Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)

Who this might be right for
NMOSD
Xiamen Hospital of Traditional Chinese Medicine 4,000
Testing effectiveness (Phase 2)Study completedNCT04614454
What this trial is testing

High Frequency Impulse Therapy for Neuropathic Pain in NMOSD

Who this might be right for
Neuromyelitis Optica
Massachusetts General Hospital 46
Not applicableUnknownNCT05446701
What this trial is testing

Assessment of Serum FAM19A5 Level in Egyptian Patients With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Assessment of Serum FAM19A5level in Egyptian Patients With NMOSD
Assiut University 120
Not applicableStudy completedNCT03819413
What this trial is testing

Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University Hospital

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Assiut University 90
Very early researchWithdrawnNCT06548620
What this trial is testing

RD06-04 in Patients With Active Autoimmune Diseases

Who this might be right for
SLESclerosisANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd.
Not applicableNot Yet RecruitingNCT07304960
What this trial is testing

Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder

Who this might be right for
MS (Multiple Sclerosis)NMO Spectrum Disorder (NMOSD)
Assiut University 100
Early research (Phase 1)WithdrawnNCT02087813
What this trial is testing

Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses

Who this might be right for
Neuromyelitis Optica
Stanford University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07804004
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease

Who this might be right for
Progressive Multiple Sclerosis (PMS)Neuromyelitis OpticaMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more
CRISPR Therapeutics 220
Next Page